Express Scripts denied your biologics? What to do next

Quick answer

If Express Scripts (Evernorth) denied your biologic and infusion therapy, you can appeal, and the plan must give you its file and the criteria it used. Filing windows by plan type: at least 180 days (employer self-funded plans); at least 180 days (insured and Marketplace plans). The date printed on your denial notice controls; it can only be later than these floors, never earlier.

Why Express Scripts (Evernorth) denies biologic and infusion therapy

Express Scripts is a pharmacy benefit manager owned by Cigna's Evernorth, and it decides drug coverage for employers, health plans and Medicare Part D sponsors rather than insuring you directly. That distinction is the reason most Express Scripts appeals go wrong: the denial arrives on Express Scripts letterhead, but the rules that govern your appeal come from whoever sponsors your plan. Sorting out which plan you are actually in is the first move, not an afterthought.

For biologic and infusion therapy specifically: Biologics such as adalimumab, infliximab, vedolizumab, ustekinumab, and rituximab are denied at prior authorization for step-therapy, missing labs, or diagnosis mismatch, and later for site of care or dose escalation. The appeal is a documentation exercise against the plan's own criteria.

The law that controls this appeal

Plan drug policies typically require a specific diagnosis, disease severity measures, a trial of conventional therapy (step therapy), tuberculosis and hepatitis screening, and prescriber specialty. Many states limit step therapy and require exception processes; federal rules for ACA plans require an exceptions process for non-formulary drugs (45 CFR 156.122(c)). Medicare Part B covers physician-administered biologics under medical necessity; Part D covers self-administered ones under formulary rules with a 60-day redetermination window (42 CFR 423.582). Criteria must be disclosed on request (29 CFR 2560.503-1(m)(8)).

At a glance

Express Scripts (Evernorth) appeals: the rule, the deadline and the next level, by plan type

Which row applies depends on the plan you hold, not on Express Scripts (Evernorth)'s brand. Your ID card, the Summary Plan Description and the denial letter say which.

Plan type	Rule that governs	File your appeal within	The plan must answer	If the plan says no again
Employer self-funded plan (ERISA) Most large employers. The employer pays the claims and hires the carrier to administer them; the Summary Plan Description says self-funded or self-insured.	ERISA § 503 (29 U.S.C. § 1133) and the claims-procedure rule, 29 CFR 2560.503-1. Federal external review under 45 CFR 147.136(d) for non-grandfathered plans.	At least 180 days from the adverse benefit determination (29 CFR 2560.503-1(h)(3)(i)).	Urgent care: 72 hours. Pre-service: 30 days. Post-service: 60 days (29 CFR 2560.503-1(i)(2)).	Federal external review by an accredited independent review organization, requested within 4 months of the final internal denial (45 CFR 147.136(d)); then a civil action under ERISA § 502(a). State insurance departments do not regulate self-funded plans; the U.S. Department of Labor does.
Fully insured employer, individual or Marketplace plan The carrier holds the risk and is licensed in your state. Small employers and almost all individual and HealthCare.gov plans.	45 CFR 147.136 (Public Health Service Act § 2719), which applies the 29 CFR 2560.503-1 procedures and adds state external review; state insurance law on top.	At least 180 days from the denial (45 CFR 147.136(b); 29 CFR 2560.503-1(h)(3)(i)).	Urgent care: 72 hours. Pre-service: 30 days. Post-service: 60 days. Prior-authorization decisions by Marketplace issuers from 2026: 72 hours expedited, 7 calendar days standard (CMS-0057-F).	External review through your state's process, or the federal process where the state has none, generally within 4 months of the final internal denial (45 CFR 147.136(c), (d)). The state insurance department and its Consumer Assistance Program take complaints.

Employer self-funded plan (ERISA)

What you can demand. The plan must give you the claim file, the internal rule or criterion it relied on, and the identity of the reviewer, free of charge, on request (29 CFR 2560.503-1(h)(2)(iii), (m)(8)).

How to open the appeal. Cite ERISA § 503 and 29 CFR 2560.503-1 in the opening paragraph: request the claim file and the specific criteria relied on, and note the 30-day (pre-service), 60-day (post-service) and 72-hour (urgent) decision clocks.

Fully insured employer, individual or Marketplace plan

What you can demand. The plan must give you the claim file, the criteria it applied and any new evidence or rationale before the final decision, free of charge (45 CFR 147.136(b)(2)(ii)(C); 29 CFR 2560.503-1(h)(2)(iii)).

How to open the appeal. Cite 45 CFR 147.136 and 29 CFR 2560.503-1: request the claim file and the criteria, note the decision clocks, and name the state external-review right.

Primary sources for this table

Windows are federal floors or the rule as written; the denial notice controls. Reviewed 13 September 2026. General information, not legal advice; Apellica is not a law firm.

What Express Scripts (Evernorth) denies for biologic and infusion therapy

The biologic and infusion therapy services most often denied:

First biologic for Crohn's disease, ulcerative colitis, rheumatoid arthritis, psoriatic arthritis, or psoriasis
Switch to a second biologic after the first stops working
Dose escalation or interval shortening beyond the label
Infusion at a hospital outpatient department instead of home or a standalone center
Biosimilar substitution disputes

Why biologic and infusion therapy claims get denied

A typical Express Scripts (Evernorth) biologic and infusion therapy denial almost always cites one of these reasons. Each one maps to a specific rebuttal in the appeal:

Step therapy: conventional drugs (methotrexate, mesalamine, steroids) not tried or not documented
Disease activity scores or lab markers missing from the record
Diagnosis code does not match the labeled indication
TB or hepatitis B screening not on file
Plan prefers a different biologic or a biosimilar first

The Express Scripts (Evernorth) appeal process

Appeal levels: An internal appeal to the plan, which Express Scripts administers, and then the external lane that matches your plan type: independent external review for commercial and employer plans, or the Part D appeals ladder through an independent review entity for Medicare.

Carrier timing: Employer and commercial plans generally allow at least 180 days from the denial to file the internal appeal. Medicare Part D runs on much shorter deadlines, and urgent requests are faster again. The date printed on your denial letter controls, and it is the date on the letter that starts the clock.

Biologics timing: Untreated inflammatory disease supports an expedited appeal: decision within 72 hours. Internal appeal filing window: at least 180 days for commercial and employer plans; 65 days for Medicare Advantage; 60 days for Part D. External review: within 4 months of the final internal denial for ACA-covered plans (45 CFR 147.136).

What we know about Express Scripts (Evernorth): Ask for two things in writing at the same time as the appeal: the specific coverage criteria the decision was applied against, and confirmation of whether your plan is self-funded or fully insured. The second answer determines your external-review route, and plans are required to tell you.

Common Express Scripts (Evernorth) denial patterns for biologic and infusion therapy

Formulary exclusion mistaken for medical necessity. A large share of Express Scripts denials are formulary exclusions: the drug is not covered on your plan's list, regardless of whether it is right for you. Appealing that as a medical-necessity argument usually fails, because nobody disputed the medicine. The route is a formulary exception, which asks the plan to cover a non-covered drug because the covered alternatives are unsuitable, and it needs the prescriber to say why in clinical terms.
Step therapy and the missing trial record. Express Scripts commonly requires documented trial and failure of preferred alternatives first. Denials cite the absence of that record far more often than they dispute the diagnosis. The fix is a prescriber statement naming each drug tried, the dose, the duration and the specific reason it was stopped. Most state step-therapy laws also allow an override where the alternative is contraindicated, was already tried, or is expected to be ineffective.
The plan sponsor sets the appeal rules, not the PBM. If your plan is an employer self-funded plan, federal ERISA rules give you at least 180 days to appeal and entitle you to the criteria and the claim file on request. If it is a fully insured plan, your state's rules and external review apply. If it is Medicare Part D, a different and much faster set of deadlines applies. Express Scripts administers all three, so the letterhead tells you nothing about which clock you are on.
Part D runs on a far shorter clock. Medicare Part D coverage determinations and redeterminations move in days, not months, and an expedited request compresses them further. Treating a Part D denial with a commercial-plan timetable is the most common way people lose the right to appeal it at all.

How to win your Express Scripts (Evernorth) biologic and infusion therapy appeal

Strategy for biologic and infusion therapy: Get the plan's drug policy and match every criterion to a page in the chart: diagnosis, severity score, prior drugs with dates and outcomes, screening labs, prescriber specialty. Where step therapy is the reason, use the plan's exception process and, where applicable, the state step-therapy law that requires an override when the required drug was tried, is contraindicated, or is expected to be ineffective. For a switch after loss of response, document the objective loss of response. Ask for a peer-to-peer with a reviewer in the same specialty.

Filed against Express Scripts (Evernorth), that strategy rides on this procedural spine:

Procedural-rights anchor. Cite ERISA § 503 and 29 CFR 2560.503-1 in the opening paragraph: request the claim file and the specific criteria relied on, and note the 30-day (pre-service), 60-day (post-service) and 72-hour (urgent) decision clocks. If your Express Scripts (Evernorth) coverage is a different plan type (Fully insured employer, individual or Marketplace plan), use that row of the table above instead; the rule and the deadline change with the plan, not the carrier.
Criteria-disclosure demand. Express Scripts (Evernorth) frequently denies on "not medically necessary" without disclosing the clinical criteria applied. Once disclosed, those criteria become the rebuttal map.
Controlling-standard citation. Plan drug policies typically require a specific diagnosis, disease severity measures, a trial of conventional therapy (step therapy), tuberculosis and hepatitis screening, and prescriber specialty. Many states limit step therapy and require exception processes; federal rules for ACA plans require an exceptions process for non-formulary drugs (45 CFR 156.122(c)). Medicare Part B covers physician-administered biologics under medical necessity; Part D covers self-administered ones under formulary rules with a 60-day redetermination window (42 CFR 423.582). Criteria must be disclosed on request (29 CFR 2560.503-1(m)(8)).
Treating-provider attestation. A letter from the treating physician addressing each criterion in Express Scripts (Evernorth)'s own policy language. This is the single strongest evidentiary element.
Requested action. A specific demand to reverse the biologic and infusion therapy denial and approve the service, not a general "please reconsider."

Documents you'll need for your Express Scripts (Evernorth) biologic and infusion therapy appeal

The denial letter with the criterion or policy cited
Specialist's notes with diagnosis and disease-activity measures
Prior medication history with dates, doses, and outcomes
TB, hepatitis, and other screening results
The plan's drug policy and formulary exception form

What a biologic and infusion therapy appeal can recover

Typical recovery for biologic and infusion therapy cases runs Biologics are priced in the thousands of dollars per dose; a denied year of therapy is commonly a five-figure sum at billed charges.. The exact figure depends on the specific service and your plan's contracted rates.

Express Scripts (Evernorth) biologic and infusion therapy appeals: frequently asked questions

Express Scripts (Evernorth) wants me to fail a cheaper drug first. Do I have to?

Not always. Plans must have an exception process, and many states require an override when the required drug was already tried, is contraindicated, or is expected to be ineffective. The prescriber's letter should say which of those applies and why.

Why was my biologic denied when my doctor prescribed it?

Most denials are documentation gaps: a missing severity score, an undocumented prior drug, or a screening lab not on file. The plan's policy tells you exactly which item is missing; request it.

Express Scripts (Evernorth) moved my infusions out of the hospital. Can I appeal the site of care?

Yes. Site-of-care denials are appealable. The record needs to show why the hospital setting is medically required, for example prior infusion reactions or complex comorbidities.

Is a biosimilar the same drug?

A biosimilar is highly similar to the reference biologic with no clinically meaningful difference, per FDA. Plans may prefer one. If a switch caused loss of response or an adverse reaction, that history is the basis for an exception.

What Apellica does for Express Scripts (Evernorth) biologic and infusion therapy appeals

We file appeals against Express Scripts (Evernorth) specifically configured to its internal review process. Every biologic and infusion therapy appeal embeds the criteria-disclosure demand, the procedural-rights anchor, the controlling-standard citation above, treating-provider attestation language, and the peer-reviewed evidence relevant to the denied service.

Cost: $0 upfront. We work on contingency for Express Scripts (Evernorth) appeals, if the appeal succeeds, we collect a percentage of the recovered claim value. If it fails, you owe nothing.

Start your Express Scripts (Evernorth) biologic and infusion therapy appeal

Submit a 2-minute intake. A senior reviewer responds within one business day with the specific appeal strategy for your case.

Start free appeal review →

Express Scripts (Evernorth) denied your biologic and infusion therapy? Here is what to do next